Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Previous issues

Page Path
HOME > Browse articles > Previous issues
16 Previous issues
Filter
Filter
Article category
Keywords
Authors
Volume 13(2); April 2015
Prev issue Next issue
Editorials
Application of Endoscopic Ultrasonography in the Diagnosis and Treatment of Lower Gastrointestinal Disease
Eun Young Kim
Intest Res 2015;13(2):101-102.   Published online April 27, 2015
DOI: https://doi.org/10.5217/ir.2015.13.2.101
PDFPubReader

Citations

Citations to this article as recorded by  
  • Clinical significance of computed tomography-detected ascites in gastric cancer patients with peritoneal metastases
    Su Hwan Kim, Young Ho Choi, Ji Won Kim, Sohee Oh, Seohui Lee, Byeong Gwan Kim, Kook Lae Lee
    Medicine.2018; 97(8): e9343.     CrossRef
  • 9,147 View
  • 36 Download
  • 1 Web of Science
  • 1 Crossref
Close layer
Are Small Rectal Neuroendocrine Tumors Safe?
Jae Ho Choi, Jae Myung Cha
Intest Res 2015;13(2):103-104.   Published online April 27, 2015
DOI: https://doi.org/10.5217/ir.2015.13.2.103
PDFPubReader

Citations

Citations to this article as recorded by  
  • The role of endoscopic ultrasonography for diagnosis of residual rectal neuroendocrine tumor
    Seong-Jung Kim, Jun Lee, Gang-Woo Kim, So Yeong Kim
    Surgical Endoscopy.2024; 38(8): 4260.     CrossRef
  • 4,443 View
  • 41 Download
  • 1 Web of Science
  • 1 Crossref
Close layer
Reviews
Myeloid-Derived Suppressor Cells in Inflammatory Bowel Disease
Yeon-Jeong Kim, Sun-Young Chang, Hyun-Jeong Ko
Intest Res 2015;13(2):105-111.   Published online April 27, 2015
DOI: https://doi.org/10.5217/ir.2015.13.2.105
AbstractAbstract PDFPubReader

Immature myeloid cells, also known as myeloid-derived suppressor cells (MDSCs), include neutrophilic and monocytic myeloid cells, and are found in inflammatory loci and secondary lymphoid organs in mice with intestinal inflammation, inflammatory bowel disease (IBD) patients, and tumor tissues. However, the roles of MDSCs in IBD are not yet well understood, and there are controversies regarding their immunosuppressive functions in IBD. In addition, recent studies have suggested that endoplasmic reticulum (ER) stress in intestinal epithelial cells, especially in Paneth cells, is closely associated with the induction of IBD. However, the ER stress in MDSCs accumulated in the inflamed tissues of IBD patients is not yet fully understood. In the current review, we discuss the presence of accumulated MDSCs in the intestines of IBD patients, and further speculate on their physiological roles in the inflammatory condition with interleukin 17-producing cells, including Th17 cells. In particular, we will discuss the divergent functions of MDSCs in ER stressed intestinal environments, including their pro-inflammatory or immunosuppressive roles, based on the consideration of unfolded protein responses initiated in intestinal epithelial cells by ER stress.

Citations

Citations to this article as recorded by  
  • Sulforaphane Attenuates AOM/DSS-Induced Colorectal Tumorigenesis in Mice via Inhibition of Intestinal Inflammation
    Fang Shao, Jie Pan, Yewen Xie, Jun Ding, Xiao Sun, Lei Xia, Dawei Zhu, Shizhong Wang, Chunjian Qi
    Nutrition and Cancer.2024; 76(1): 137.     CrossRef
  • Local administration of myeloid-derived suppressor cells prevents progression of immune-mediated dry eye disease
    Pier Luigi Surico, Seokjoo Lee, Rohan Bir Singh, Amirreza Naderi, Shilpy Bhullar, Tomas Blanco, Yihe Chen, Reza Dana
    Experimental Eye Research.2024; 242: 109871.     CrossRef
  • Dexamethasone promotes renal fibrosis by upregulating ILT4 expression in myeloid‐derived suppressor cells
    Xiaowen Gu, Lianmei Zhang, Min Sun, Ying Zhou, Jinling Ji, YunFang Xu, Jianguo You, Zhikui Deng
    Journal of Cellular and Molecular Medicine.2024;[Epub]     CrossRef
  • Endoplasmic reticulum stress mediates the myeloid-derived immune suppression associated with cancer and infectious disease
    Xiaoli Lou, Deyong Gao, Liyuan Yang, Yue Wang, Yanqiang Hou
    Journal of Translational Medicine.2023;[Epub]     CrossRef
  • Mesenchymal Stem Cells and Myeloid-Derived Suppressor Cells Interplay in Adjuvant-Induced Arthritis Rat Model
    Faten A.M. Abo-Aziza, Basma M. Wasfy, Sanaa M.R. Wahba, Sahar S. Abd-Elhalem
    International Immunopharmacology.2023; 120: 110300.     CrossRef
  • TMPRSS11D/ALR-mediated ER stress regulates the function of myeloid-derived suppressor cells in the cervical cancer microenvironment
    Sifang Feng, Juan Zhao, Ting Yang, Long Li
    International Immunopharmacology.2023; 124: 110869.     CrossRef
  • Glycolysis inhibition ameliorates brain injury after ischemic stroke by promoting the function of myeloid-derived suppressor cells
    Jingwei Yan, Anqi Li, Xianglin Chen, Kaixiang Cao, Mingchuan Song, Shuai Guo, Zou Li, Shuqi Huang, Ziling Li, Danghan Xu, Yong Wang, Xiaoyan Dai, Du Feng, Yuqing Huo, Jun He, Yiming Xu
    Pharmacological Research.2022; 179: 106208.     CrossRef
  • Myeloid-derived suppressor cells in transplantation tolerance induction
    Peng Cao, Zejia Sun, Chang Feng, Jiandong Zhang, Feilong Zhang, Wei Wang, Yong Zhao
    International Immunopharmacology.2020; 83: 106421.     CrossRef
  • Myeloid-Derived Suppressor Cell-Derived Arginase-1 Oppositely Modulates IL-17A and IL-17F Through the ESR/STAT3 Pathway During Colitis in Mice
    Zhanchuan Ma, Yu Zhen, Cong Hu, Huanfa Yi
    Frontiers in Immunology.2020;[Epub]     CrossRef
  • Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5/14
    Simon H. Murch
    Medical Hypotheses.2020; 144: 110168.     CrossRef
  • Immunometabolism: Another Road to Sepsis and Its Therapeutic Targeting
    Vijay Kumar
    Inflammation.2019; 42(3): 765.     CrossRef
  • Glatiramer Acetate Enhances Myeloid-Derived Suppressor Cell Function via Recognition of Paired Ig-like Receptor B
    William van der Touw, Kyeongah Kang, Yi Luan, Ge Ma, Sunny Mai, Lihui Qin, Guanglin Bian, Ruihua Zhang, Sathish Kumar Mungamuri, Hong-Ming Hu, Cheng Cheng Zhang, Stuart A Aaronson, Marc Feldmann, Wen-Chin Yang, Shu-Hsia Chen, Ping-Ying Pan
    The Journal of Immunology.2018; 201(6): 1727.     CrossRef
  • The Expansion of Myeloid-Derived Suppressor Cells Is Associated with Joint Inflammation in Rheumatic Patients with Arthritis
    Junqing Zhu, Shixian Chen, Lisheng Wu, Ran Wang, Songyuan Zheng, Di Zhao, Xiangyang Wang, Juan Li
    BioMed Research International.2018; 2018: 1.     CrossRef
  • Lymph node macrophages: drug-related reaction or infectious-lesion?
    Adriana Handra-Luca
    Intestinal Research.2018; 16(4): 646.     CrossRef
  • TGF-Β as a Marker of Ulcerative Colitis and Disease Severity
    Marina Jovanovic, Natasa Zdravkovic, Ivan Jovanovic, Gordana Radosavljevic, Nevena Gajovic, Nebojsa Zdravkovic, Veljko Maric, Nebojsa Arsenijevic
    Serbian Journal of Experimental and Clinical Research.2018; 19(3): 229.     CrossRef
  • Roles of Myeloid-Derived Suppressor Cell Subpopulations in Autoimmune Arthritis
    Min Li, Dongwei Zhu, Tingting Wang, Xueli Xia, Jie Tian, Shengjun Wang
    Frontiers in Immunology.2018;[Epub]     CrossRef
  • Chlorogenic acid suppresses lipopolysaccharide-induced nitric oxide and interleukin-1β expression by inhibiting JAK2/STAT3 activation in RAW264.7 cells
    Sang-Hun Kim, Sun-Young Park, Young-Lan Park, Dae-Seong Myung, Jong-Sun Rew, Young-Eun Joo
    Molecular Medicine Reports.2017; 16(6): 9224.     CrossRef
  • The potential therapeutic role of myeloid-derived suppressor cells in autoimmune arthritis
    Yungang Wang, Jie Tian, Shengjun Wang
    Seminars in Arthritis and Rheumatism.2016; 45(4): 490.     CrossRef
  • Oral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel disease
    Yaron Ilan
    Clinical & Translational Immunology.2016;[Epub]     CrossRef
  • The Crosstalk between Myeloid Derived Suppressor Cells and Immune Cells: To Establish Immune Tolerance in Transplantation
    Chao Zhang, Shuo Wang, Cheng Yang, Ruiming Rong
    Journal of Immunology Research.2016; 2016: 1.     CrossRef
  • Exosomes released by granulocytic myeloid-derived suppressor cells attenuate DSS-induced colitis in mice
    Yungang Wang, Jie Tian, Xinyi Tang, Ke Rui, Xinyu Tian, Jie Ma, Bin Ma, Huaxi Xu, Liwei Lu, Shengjun Wang
    Oncotarget.2016; 7(13): 15356.     CrossRef
  • 5,932 View
  • 92 Download
  • 21 Web of Science
  • 21 Crossref
Close layer
Epigenetic Alterations in Inflammatory Bowel Disease and Cancer
Joo Mi Yi, Tae Oh Kim
Intest Res 2015;13(2):112-121.   Published online April 27, 2015
DOI: https://doi.org/10.5217/ir.2015.13.2.112
AbstractAbstract PDFPubReader

Overwhelming evidences supports the idea that inflammatory bowel disease (IBD) is caused by a complex interplay between genetic alterations of multiple genes and an aberrant interaction with environmental factors. There is growing evidence that epigenetic factors can play a significant part in the pathogenesis of IBD. Significant effort has been invested in uncovering genetic and epigenetic factors, which may increase the risk of IBD, but progress has been slow, and few IBD-specific factors have been detected so far. It has been known for decades that DNA methylation is the most well studied epigenetic modification, and analysis of DNA methylation is leading to a new generation of cancer biomarkers. Therefore, in this review, we summarize the role of DNA methylation alteration in IBD pathogenesis, and discuss specific genes or genetic loci using recent molecular technology advances. Here, we suggest that DNA methylation should be studied in depth to understand the molecular pathways of IBD pathogenesis, and discuss epigenetic studies of IBD that may have a significant impact on the field of IBD research.

Citations

Citations to this article as recorded by  
  • Personalized Medicine for IBD Patients
    Nina Fadeeva, Igor Khatkov, Natalia Bodunova, Oleg Knyazev, Dmitry Bordin, Asfold Parfenov, Karina Nikolskaya, Sergey Nikolaev, Konstantin Rumyantsev, Vera Polyakova, Tatiana Yanova
    BioNanoScience.2023; 13(1): 330.     CrossRef
  • Epigenetic Changes and Its Intervention in Age-Related Neurodegenerative Diseases
    Nuraqila Mohd Murshid, Faridah Aminullah Lubis, Suzana Makpol
    Cellular and Molecular Neurobiology.2022; 42(3): 577.     CrossRef
  • Role of diet and nutrition in inflammatory bowel disease
    Marina Moreira de Castro, Lívia Bitencourt Pascoal, Karine Mariane Steigleder, Beatriz Piatezzi Siqueira, Ligiana Pires Corona, Maria de Lourdes Setsuko Ayrizono, Marciane Milanski, Raquel Franco Leal
    World Journal of Experimental Medicine.2021; 11(1): 1.     CrossRef
  • Genome-Wide Analysis of the DNA Methylation Profile Identifies the Fragile Histidine Triad (FHIT) Gene as a New Promising Biomarker of Crohn’s Disease
    Tae-Oh Kim, Dong-Il Park, Yu Han, Keunsoo Kang, Sae-Gwang Park, Hae Park, Joo Yi
    Journal of Clinical Medicine.2020; 9(5): 1338.     CrossRef
  • Aberrant methylation and microRNA-target regulation are associated with downregulated NEURL1B: a diagnostic and prognostic target in colon cancer
    Jiaxin Liu, Zhao Liu, Xiaozhi Zhang, Yanli Yan, Shuai Shao, Demao Yao, Tuotuo Gong
    Cancer Cell International.2020;[Epub]     CrossRef
  • Effect of Perfluorooctanoic Acid on the Epigenetic and Tight Junction Genes of the Mouse Intestine
    Faizan Rashid, Saeed Ahmad, Joseph Maria Kumar Irudayaraj
    Toxics.2020; 8(3): 64.     CrossRef
  • Epigenetics, DNA Organization, and Inflammatory Bowel Disease
    Greeshma Ray, Michelle S Longworth
    Inflammatory Bowel Diseases.2019; 25(2): 235.     CrossRef
  • Impaired nutritional status in outpatients in remission or with active Crohn's disease – classified by objective endoscopic and imaging assessments
    Marina Moreira de Castro, Ligiana Pires Corona, Lívia Bitencourt Pascoal, Bruno Lima Rodrigues, Maria de Lourdes Setsuko Ayrizono, Claudio Saddy Rodrigues Coy, Raquel Franco Leal, Marciane Milanski
    Clinical Nutrition ESPEN.2019; 33: 60.     CrossRef
  • Hepatitis B Virus Infection Is Independently Associated With Advanced Colorectal Adenoma
    Su Hwan Kim, Ji Won Kim, Kook Lae Lee, Seohui Lee, Seong-Joon Koh, Ji Bong Jeong, Byeong Gwan Kim
    The American Journal of the Medical Sciences.2018; 356(2): 141.     CrossRef
  • Protocol for Fecal Microbiota Transplantation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
    Haiming Fang, Lian Fu, Jiajia Wang
    BioMed Research International.2018; 2018: 1.     CrossRef
  • Epigenetic modulation of intestinal Na+/H+ exchanger-3 expression
    Anoop Kumar, Pooja Malhotra, Hayley Coffing, Shubha Priyamvada, Arivarasu N. Anbazhagan, Harish R. Krishnan, Ravinder K. Gill, Waddah A. Alrefai, David P. Gavin, Subhash C. Pandey, Pradeep K. Dudeja, Seema Saksena
    American Journal of Physiology-Gastrointestinal and Liver Physiology.2018; 314(3): G309.     CrossRef
  • Is there a potential role of fecal microbiota transplantation in the treatment of inflammatory bowel disease?
    Chang Soo Eun
    Intestinal Research.2017; 15(2): 145.     CrossRef
  • Lack of Aberrant Methylation in an Adjacent Area of Left-Sided Colorectal Cancer
    Otgontuya Sambuudash, Hyun-Soo Kim, Mee Yon Cho
    Yonsei Medical Journal.2017; 58(4): 749.     CrossRef
  • The colon revisited or the key to wellness, health and disease
    C.A. Gonzalez-Correa, E. Mulett-Vásquez, D.A. Miranda, C.H. Gonzalez-Correa, P.A. Gómez-Buitrago
    Medical Hypotheses.2017; 108: 133.     CrossRef
  • The contribution of long non-coding RNAs in Inflammatory Bowel Diseases
    Eirini Zacharopoulou, Maria Gazouli, Maria Tzouvala, Antonios Vezakis, George Karamanolis
    Digestive and Liver Disease.2017; 49(10): 1067.     CrossRef
  • Epigenetic silencing of NDRG2 promotes colorectal cancer proliferation and invasion
    Sung Noh Hong, Sung Jin Kim, Eun‐Ran Kim, Dong Kyung Chang, Young‐Ho Kim
    Journal of Gastroenterology and Hepatology.2016; 31(1): 164.     CrossRef
  • Inflammatory Bowel Disease: Genetics, Epigenetics, and Pathogenesis
    Italia Loddo, Claudio Romano
    Frontiers in Immunology.2015;[Epub]     CrossRef
  • The genetic architecture of inflammatory bowel disease
    Isabelle Cleynen, Séverine Vermeire
    Current Opinion in Gastroenterology.2015;[Epub]     CrossRef
  • Epigenetic Modification and Its Role in Alzheimer's Disease
    Yi-Ping Zhu, Ya Feng, Te Liu, Yun-Cheng Wu
    Integrative Medicine International.2015; 2(1-2): 63.     CrossRef
  • 20,309 View
  • 67 Download
  • 26 Web of Science
  • 19 Crossref
Close layer
Original Articles
Increased Risk of Asymptomatic Gallstones in Patients With Ulcerative Colitis
Jung Hoon Ha, Young Sook Park, Choon Sik Seon, Byung Kwan Son, Sang Bong Ahn, Young Kwan Jo, Seong Hwan Kim, Yun Ju Jo, Jung Hwan Kim, Jee Hye Han, Yoon Young Jung, Sook Hee Chung
Intest Res 2015;13(2):122-127.   Published online April 27, 2015
DOI: https://doi.org/10.5217/ir.2015.13.2.122
AbstractAbstract PDFPubReader
<b>Background/Aims</b><br/>

The relationship between Crohn's disease and gallstones is established. However, the prevalence and risk factors for gallstones in patients with ulcerative colitis (UC) are not yet well understood. The aim of this study was to evaluate the prevalence and risk factors of gallstones in patients with UC.

Methods

This study was a retrospective single center study. A total of 87 patients with UC and 261 healthy controls were enrolled. Age, sex, and body mass index were matched. To investigate risk factors, the extent of UC, duration of disease, number of hospital admissions, and number of steroid treatments in patients with UC were evaluated.

Results

The prevalence of gallstones in patients with UC was 13.8%, whereas that in healthy controls was only 3.1% (P<0.001). For patients with UC, patients ≥50 years of age had a 3.6-times higher risk of gallstones compared to that in those <50 years of age, and the difference was statistically significant (odds ratio, 3.60; confidence interval, 1.03-12.61) in univariate analysis. There were no statistically significant disease-related risk factors for gallstones in UC patients.

Conclusions

This is the first study of gallstone prevalence in Korean UC patients. In this study, patients with UC had a higher prevalence of gallstones compared to that in well-matched healthy controls. Age seemed to be a possible risk factor, and more studies are needed. Further prospective, large-scale studies will be required to confirm the risk factors for gallstones in UC patients.

Citations

Citations to this article as recorded by  
  • Prevalence of Gallstones in Ulcerative Colitis and Crohn’s Disease: A Systematic Review and Meta-Analysis
    Mirza M. A Baig, Shayan A Irfan, Anusha Sumbal, Ramish Sumbal, Sanjay Kumar, Junaid Ahmad, Nikhila Gandrakota, Laila Tul Qadar, Maida S Chaudhry, Azka Feroz, Muhammad Sheharyar Warraich
    Cureus.2022;[Epub]     CrossRef
  • Comorbidity in children with gallstone disease
    S. Yu. Matalaeva, V. A. Shashel
    Experimental and Clinical Gastroenterology.2021; 1(1): 89.     CrossRef
  • Gallstone disease in children and comorbiditi
    S. Yu. Matalayeva
    Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics).2021; 66(3): 34.     CrossRef
  • Association between Inflammatory Bowel Disease and Cholelithiasis: A Nationwide Population-Based Cohort Study
    Chien-Hua Chen, Cheng-Li Lin, Chia-Hung Kao
    International Journal of Environmental Research and Public Health.2018; 15(3): 513.     CrossRef
  • Gallstone prevalence and risk factors in patients with ulcerative colitis in Korean population
    Yo Han Jeong, Kyeong Ok Kim, Ho Chan Lee, Se Hoon Sohn, Jung Woo Lee, Si Hyung Lee, Byung Ik Jang, Tae Nyeun Kim
    Medicine.2017; 96(31): e7653.     CrossRef
  • The Risk of Gallstone Disease Following Colectomy for Ulcerative Colitis
    Cong Dai, Min Jiang, Ming-Jun Sun
    American Journal of Gastroenterology.2017; 112(7): 1165.     CrossRef
  • Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseases
    Stefania Fagagnini, Henriette Heinrich, Jean-Benoît Rossel, Luc Biedermann, Pascal Frei, Jonas Zeitz, Marianne Spalinger, Edouard Battegay, Lukas Zimmerli, Stephan R. Vavricka, Gerhard Rogler, Michael Scharl, Benjamin Misselwitz, John Green
    PLOS ONE.2017; 12(10): e0185193.     CrossRef
  • 5,172 View
  • 41 Download
  • 6 Web of Science
  • 7 Crossref
Close layer
What's the Clinical Features of Colitis in Elderly People in Long-Term Care Facilities?
So Yoon Yoon, Sung-Ae Jung, Sun-Kyung Na, Jae-In Ryu, Hye-Won Yun, Min-Jin Lee, Eun-Mi Song, Seong-Eun Kim, Hye-Kyung Jung, Ki-Nam Shim
Intest Res 2015;13(2):128-134.   Published online April 27, 2015
DOI: https://doi.org/10.5217/ir.2015.13.2.128
AbstractAbstract PDFPubReader
<b>Background/Aims</b><br/>

As life expectancy has increased, the number of elderly patients who need long-term care has grown rapidly. Mortality in patients with colitis in long-term care facilities (LTCFs) is increasing. We intend to investigate the main causes of colitis in LTCFs compared to those of colitis in local communities, and to identify the clinical features and risk factors of patients with colitis in LTCFs.

Methods

We retrospectively analyzed epidemiology, medical conditions, laboratory values, diagnoses, and clinical courses of elderly patients aged ≥65 who were admitted to the Ewha Womans University hospital with colitis between January 2007 and July 2012.

Results

Patients with colitis in LTCFs (n=20) were compared with elderly patients with colitis in local communities (n=154). Fifty-five percent of colitis in LTCFs was caused by Clostridium difficile infection (CDI), 30% was due to ischemic colitis, and 15% was due to non-specific colitis. Non-specific colitis was the most common (63%) in the community group. Clinical outcomes were also significantly different between both groups: higher mortality (10.0% vs. 0.64%, P=0.021), higher requirement for intensive care units care (50.0% vs. 18.8%, P<0.01) in LTCFs group. In univariate analysis, the most significant risk factor for death in patients in LTCFs was decreased mental faculties.

Conclusions

Patients in LTCFs showed worse clinical outcomes and a much higher prevalence of CDI compared to patients from local communities. We suggest early and active evaluation, such as endoscopic examination, for differential diagnosis in patients in LTCFs.

Citations

Citations to this article as recorded by  
  • RecurrentClostridium difficileInfection: Risk Factors, Treatment, and Prevention
    Jung Hoon Song, You Sun Kim
    Gut and Liver.2019; 13(1): 16.     CrossRef
  • A Comprehensive Review of the Diagnosis and Pharmacological Management of Crohn’s Disease in the Elderly Population
    David Kim, Sasha Taleban
    Drugs & Aging.2019; 36(7): 607.     CrossRef
  • Rapid and accurate diagnosis of Clostridium difficile infection by real-time polymerase chain reaction
    Pil Hun Song, Jung Hwa Min, You Sun Kim, Soo Yeon Jo, Eun Jin Kim, Kyung Jin Lee, Jeonghun Lee, Hyun Sung, Jeong Seop Moon, Dong Hee Whang
    Intestinal Research.2018; 16(1): 109.     CrossRef
  • Acute hemorrhagic rectal ulcer syndrome: Comparison with non‐hemorrhagic rectal ulcer lower gastrointestinal bleeding
    Joo Hyuk Jung, Jong Wook Kim, Hyun Woo Lee, Min Yong Park, Woo Hyun Paik, Won Ki Bae, Nam‐Hoon Kim, Kyung‐Ah Kim, June Sung Lee
    Journal of Digestive Diseases.2017; 18(9): 521.     CrossRef
  • Coexisting cytomegalovirus infection in immunocompetent patients with Clostridium difficile colitis
    Khee-Siang Chan, Wen-Ying Lee, Wen-Liang Yu
    Journal of Microbiology, Immunology and Infection.2016; 49(6): 829.     CrossRef
  • Clinical Outcomes in Hospitalized Patients withClostridium difficileInfection by Age Group
    Ho Chan Lee, Kyeong Ok Kim, Yo Han Jeong, Si Hyung Lee, Byung Ik Jang, Tae Nyeun Kim
    The Korean Journal of Gastroenterology.2016; 67(2): 81.     CrossRef
  • 4,841 View
  • 36 Download
  • 6 Web of Science
  • 6 Crossref
Close layer
The Clinical Usefulness of Endoscopic Ultrasound-Guided Fine Needle Aspiration and Biopsy for Rectal and Perirectal Lesions
Jae Seung Soh, Ho-Su Lee, Seohyun Lee, Jungho Bae, Hyo Jeong Lee, Sang Hyoung Park, Dong-Hoon Yang, Kyung-Jo Kim, Byong Duk Ye, Seung-Jae Myung, Suk-Kyun Yang, Jin-Ho Kim, Jeong-Sik Byeon
Intest Res 2015;13(2):135-144.   Published online April 27, 2015
DOI: https://doi.org/10.5217/ir.2015.13.2.135
AbstractAbstract PDFPubReader
<b>Background/Aims</b><br/>

Endoscopic ultrasound-guided fine needle aspiration and/or biopsy (EUS-FNA/B) have been used to diagnose subepithelial tumors (SETs) and extraluminal lesions in the gastrointestinal tract. Our group previously reported the usefulness of EUS-FNA/B for rectal and perirectal lesions. This study reports our expanded experience with EUS-FNA/B for rectal and perirectal lesions in terms of diagnostic accuracy and safety. We also included our new experience with EUS-FNB using the recently introduced ProCore needle.

Methods

From April 2009 to March 2014, EUS-FNA/B for rectal and perirectal lesions was performed in 30 consecutive patients. We evaluated EUS-FNA/B performance by comparing histological diagnoses with final results. We also investigated factors affecting diagnostic accuracy.

Results

Among 10 patients with SETs, EUS-FNA/B specimen results revealed a gastrointestinal stromal tumor in 4 patients and malignant lymphoma in 1 patient. The diagnostic accuracy of EUS-FNA/B was 50% for SETs (5/10). Among 20 patients with non-SET lesions, 8 patients were diagnosed with malignant disease and 7 were diagnosed with benign disease based on both EUS-FNA/B and the final results. The diagnostic accuracy of EUS-FNA/B for non-SET lesions was 75% (15/20). The size of lesions was the only factor related to diagnostic accuracy (P=0.027). Two complications of mild fever and asymptomatic pneumoperitoneum occurred after EUS-FNA/B.

Conclusions

The overall diagnostic accuracy of EUS-FNA/B for rectal and perirectal lesions was 67% (20/30). EUS-FNA/B is a clinically useful method for cytological and histological diagnoses of rectal and perirectal lesions.

Citations

Citations to this article as recorded by  
  • Recurrent vaginal squamous cell carcinoma mimicking peri-rectal abscess: The role of endoscopic ultrasound
    Taha Bin Arif, Tahir Shaikh
    Radiology Case Reports.2025; 20(6): 2723.     CrossRef
  • Colonoscopic Ultrasound-Guided Fine-Needle Aspiration Using a Curvilinear Array Transducer: A Single-Center Retrospective Cohort Study
    Spencer Cheng, Sergio E. Matuguma, Guilherme H. P. de Oliveira, Gustavo L.R. Silva, Henrique Cheng, Sergio A. Sánchez-Luna, Mauricio K Minata
    Diseases of the Colon & Rectum.2022; 65(2): e80.     CrossRef
  • Diagnosis and Management of Rectal Neuroendocrine Tumors (NETs)
    Francesco Maione, Alessia Chini, Marco Milone, Nicola Gennarelli, Michele Manigrasso, Rosa Maione, Gianluca Cassese, Gianluca Pagano, Francesca Paola Tropeano, Gaetano Luglio, Giovanni Domenico De Palma
    Diagnostics.2021; 11(5): 771.     CrossRef
  • Long-term experience with percutaneous biopsies of pelvic lesions using CT guidance
    Petr Hoffmann, Michal Balik, Martina Hoffmannova, Jiri Spacek, Jiri Vanasek, Adam Rezac, Petr Dvorak
    Science Progress.2021;[Epub]     CrossRef
  • Prospective histological evaluation of a 20G core trap with a forward-cutting bevel needle for EUS-FNA of pancreatic lesions
    Nobu Nishioka, Takeshi Ogura, Yoshitaka Kurisu, Miyuki Imanishi, Saori Onda, Wataru Takagi, Tatsushi Sano, Atsushi Okuda, Akira Miyano, Mio Amano, Kazuhide Higuchi
    Surgical Endoscopy.2018; 32(10): 4125.     CrossRef
  • Concise review on the comparative efficacy of endoscopic ultrasound-guided fine-needle aspiration vs core biopsy in pancreatic masses, upper and lower gastrointestinal submucosal tumors
    Tawfik Khoury, Wisam Sbeit, Nicholas Ludvik, Divya Nadella, Alex Wiles, Caitlin Marshall, Manoj Kumar, Gilad Shapira, Alan Schumann, Meir Mizrahi
    World Journal of Gastrointestinal Endoscopy.2018; 10(10): 267.     CrossRef
  • Endoscopic ultrasound-guided fine needle aspiration of extra-rectal lesions
    J. Lim, S. A. Norton, N. A. Wong, M. G. Thomas
    Techniques in Coloproctology.2017; 21(5): 393.     CrossRef
  • Application of Endoscopic Ultrasonography in the Diagnosis and Treatment of Lower Gastrointestinal Disease
    Eun Young Kim
    Intestinal Research.2015; 13(2): 101.     CrossRef
  • Benign Prostatic Hyperplasia Mimicking a Symptomatic Rectal Submucosal Tumor
    Seung Wook Hong, Jaeyoung Chun, Kyu Joo Park, Cheol Kwak, Joo Sung Kim
    Soonchunhyang Medical Science.2015; 21(2): 164.     CrossRef
  • 7,215 View
  • 66 Download
  • 11 Web of Science
  • 9 Crossref
Close layer
Inhibitory Effect of Metformin Therapy on the Incidence of Colorectal Advanced Adenomas in Patients With Diabetes
Yo Han Kim, Ran Noh, Sun Young Cho, Seong Jun Park, Soung Min Jeon, Hyun Deok Shin, Suk Bae Kim, Jeong Eun Shin
Intest Res 2015;13(2):145-152.   Published online April 27, 2015
DOI: https://doi.org/10.5217/ir.2015.13.2.145
AbstractAbstract PDFPubReader
<b>Background/Aims</b><br/>

Metformin use has been associated with decreased colorectal cancer risk and mortality among diabetic patients. Recent research suggests that metformin use may decrease the incidence of colorectal adenomas in diabetic patients with previous colorectal cancer. This study aimed to assess the clinical effect of metformin use on the development of colorectal adenomas in diabetic patients without previous colorectal cancer.

Methods

Among 604 consecutive diabetic patients who underwent colonoscopic surveillance after initial colonoscopy between January 2002 and June 2012, 240 patients without previous colorectal cancer were enrolled in this study and were divided in two groups: 151 patients receiving metformin and 89 patients not receiving metformin. Patient demographics and clinical characteristics as well as the colorectal adenoma incidence rate were retrospectively analyzed.

Results

The incidence rate of total colorectal adenomas was not different according to metformin use (P=0.349). However, the advanced adenoma incidence rate was significantly lower in the metformin group compared with the non-metformin group (relative risk [RR], 0.09; P=0.011). Metformin use was independently associated with a decreased incidence of advanced colorectal adenomas after adjustment for clinically relevant factors (RR, 0.072; P=0.016). In addition, the cumulative development rate of advanced adenomas during follow-up was significantly lower in the metformin group compared with the non-metformin group (P=0.007).

Conclusions

Metformin use in diabetic patients without previous colorectal cancer is associated with a lower risk of advanced colorectal adenomas.

Citations

Citations to this article as recorded by  
  • Metformin Use Is Inversely Associated with Prevalent, but Not Incident Colorectal Adenomas
    Anna Krigel, Snow Trinh T. Nguyen, Nawar Talukder, Ching-Ho Huang, Carlos Buitrago, Gabriel Karkenny, Benjamin Lebwohl, Julian A. Abrams, James L. Araujo
    Digestive Diseases and Sciences.2022; 67(10): 4886.     CrossRef
  • The Impact of Diabetes Mellitus on the Second Primary Malignancies in Colorectal Cancer Patients
    Jana Halamkova, Tomas Kazda, Lucie Pehalova, Roman Gonec, Sarka Kozakova, Lucia Bohovicova, Ondrej Slaby, Regina Demlova, Marek Svoboda, Igor Kiss
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Suppressive effects of metformin on colorectal adenoma incidence and malignant progression
    Min Deng, Siqin Lei, Dongdong Huang, Hui Wang, Shuli Xia, Enping Xu, Yihua Wu, Honghe Zhang
    Pathology - Research and Practice.2020; 216(2): 152775.     CrossRef
  • Metformin and colorectal cancer: a systematic review, meta-analysis and meta-regression
    Cheng-Ann Winston Ng, Amy Aimei Jiang, Emma Min Shuen Toh, Cheng Han Ng, Zhi Hao Ong, Siyu Peng, Hui Yu Tham, Raghav Sundar, Choon Seng Chong, Chin Meng Khoo
    International Journal of Colorectal Disease.2020; 35(8): 1501.     CrossRef
  • Cirrhosis and insulin resistance: current knowledge, pathophysiological mechanisms, complications and potential treatments
    Frédéric Clarembeau, Georgia Bale, Nicolas Lanthier
    Clinical Science.2020; 134(16): 2117.     CrossRef
  • Age at menarche and risk of colorectal adenoma
    Nam Hee Kim, Jung Ho Park, Dong Il Park, Chong Il Sohn, Kyuyong Choi, Yoon Suk Jung
    The Korean Journal of Internal Medicine.2019; 34(5): 998.     CrossRef
  • Diabetes Mellitus: a Clinical Condition Associated with Metabolic Syndrome and Colorectal Cancer Risk
    Vesna Brzacki, Aleksandar Nagorni, Manolis Kallistratos, Athanasios Manolis, Dragan Lovic
    Current Pharmacology Reports.2019; 5(4): 205.     CrossRef
  • Diabetes Mellitus and Colon Carcinogenesis: Expectation for Inhibition of Colon Carcinogenesis by Oral Hypoglycemic Drugs
    Junichi Kato, Yohei Shirakami, Masahito Shimizu
    Gastrointestinal Disorders.2019; 1(2): 273.     CrossRef
  • Metformin Is Associated With Reduced Odds for Colorectal Cancer Among Persons With Diabetes
    Joshua Demb, Armaan Yaseyyedi, Lin Liu, Ranier Bustamante, Ashley Earles, Pradipta Ghosh, J. Silvio Gutkind, Andrew J. Gawron, Tonya R. Kaltenbach, Maria Elena Martinez, Samir Gupta
    Clinical and Translational Gastroenterology.2019; 10(11): e00092.     CrossRef
  • Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects
    Muhamad Noor Alfarizal Kamarudin, Md. Moklesur Rahman Sarker, Jin-Rong Zhou, Ishwar Parhar
    Journal of Experimental & Clinical Cancer Research.2019;[Epub]     CrossRef
  • Postoperative adjuvant chemotherapy is associated with a lower incidence of colorectal adenomas in patients with previous colorectal cancer
    Hee Seung Lee, Sung Bae Kim, Hyun Jung Lee, Soo Jung Park, Sung Pil Hong, Jae Hee Cheon, Won Ho Kim, Tae Il Kim
    Gastrointestinal Endoscopy.2018; 87(3): 688.     CrossRef
  • Metformin use and the risk of colorectal adenoma: A systematic review and meta‐analysis
    Yoon Suk Jung, Chan Hyuk Park, Chang Soo Eun, Dong Il Park, Dong Soo Han
    Journal of Gastroenterology and Hepatology.2017; 32(5): 957.     CrossRef
  • The effect of metformin on the recurrence of colorectal adenoma in diabetic patients with previous colorectal adenoma
    Min Seok Han, Hyun Jung Lee, Soo Jung Park, Sung Pil Hong, Jae Hee Cheon, Won Ho Kim, Tae Il Kim
    International Journal of Colorectal Disease.2017; 32(8): 1223.     CrossRef
  • Ursodeoxycholic acid inhibits the proliferation of colon cancer cells by regulating oxidative stress and cancer stem-like cell growth
    Eun-Kyung Kim, Jae Hee Cho, EuiJoo Kim, Yoon Jae Kim, Aamir Ahmad
    PLOS ONE.2017; 12(7): e0181183.     CrossRef
  • Serum CEA and CA 19-9 Levels are Associated with the Presence and Severity of Colorectal Neoplasia
    Nam Hee Kim, Mi Yeon Lee, Jung Ho Park, Dong Il Park, Chong Il Sohn, Kyuyong Choi, Yoon Suk Jung
    Yonsei Medical Journal.2017; 58(5): 918.     CrossRef
  • Synergistic Benefit of Statin and Metformin in Gastrointestinal Malignancies
    George K. Nimako, Zachary A. P. Wintrob, Dmitriy A. Sulik, Jennifer L. Donato, Alice C. Ceacareanu
    Journal of Pharmacy Practice.2017; 30(2): 185.     CrossRef
  • Risk Factors for False Fecal Immunochemical Test Results in Colorectal Cancer Screening
    Nam Hee Kim, Jung Ho Park, Dong Il Park, Chong Il Sohn, Kyuyong Choi, Yoon Suk Jung
    Journal of Clinical Gastroenterology.2017; 51(2): 151.     CrossRef
  • Parameters of Glucose and Lipid Metabolism Affect the Occurrence of Colorectal Adenomas Detected by Surveillance Colonoscopies
    Nam Hee Kim, Jung Yul Suh, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Kyuyong Choi, Yoon Suk Jung
    Yonsei Medical Journal.2017; 58(2): 347.     CrossRef
  • Are Hemorrhoids Associated with False-Positive Fecal Immunochemical Test Results?
    Nam Hee Kim, Jung Ho Park, Dong Il Park, Chong Il Sohn, Kyuyong Choi, Yoon Suk Jung
    Yonsei Medical Journal.2017; 58(1): 150.     CrossRef
  • Association Between Low Relative Muscle Mass and the Risk of Colorectal Neoplasms
    Yoon Suk Jung, Nam Hee Kim, Seungho Ryu, Jung Ho Park, Dong Il Park, Chong Il Sohn
    Journal of Clinical Gastroenterology.2017; 51(10): e83.     CrossRef
  • Metformin therapy and the risk of colorectal adenoma in patients with type 2 diabetes: A meta-analysis
    Yi-Chao Hou, Qiang Hu, Jiao Huang, Jing-Yuan Fang, Hua Xiong
    Oncotarget.2017; 8(5): 8843.     CrossRef
  • Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis
    Feifei Liu, Lijing Yan, Zhan Wang, Yuanan Lu, Yuanyuan Chu, Xiangyu Li, Yisi Liu, Dongsheng Rui, Shaofa Nie, Hao Xiang
    Oncotarget.2017; 8(9): 16017.     CrossRef
  • Kaffee senkt Rückfallrate bei Patienten mit Kolonkarzinom im Stadium III
    Michael Fink
    Info Onkologie.2016; 19(4): 24.     CrossRef
  • Oxidative stress and metabolic disorders: Pathogenesis and therapeutic strategies
    Vibha Rani, Gagan Deep, Rakesh K. Singh, Komaraiah Palle, Umesh C.S. Yadav
    Life Sciences.2016; 148: 183.     CrossRef
  • Weight Change and Obesity Are Associated with a Risk of Adenoma Recurrence
    Yoon Suk Jung, Jung Ho Park, Dong Il Park, Chong Il Sohn, Kyuyong Choi
    Digestive Diseases and Sciences.2016; 61(9): 2694.     CrossRef
  • 14,183 View
  • 35 Download
  • 26 Web of Science
  • 25 Crossref
Close layer
Patient Descriptions of Rectal Effluents May Help to Predict the Quality of Bowel Preparation With Photographic Examples
Hoonsub So, Sun-Jin Boo, Hyungil Seo, Ho-Su Lee, Hyojeong Lee, Sang Hyoung Park, Kyung-Jo Kim, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Jin-Ho Kim, Seungbong Han, Dong-Hoon Yang
Intest Res 2015;13(2):153-159.   Published online April 27, 2015
DOI: https://doi.org/10.5217/ir.2015.13.2.153
AbstractAbstract PDFPubReader
<b>Background/Aims</b><br/>

Previous studies have suggested a weak correlation between self-reported rectal effluent status and bowel preparation quality. We aim to evaluate whether photographic examples of rectal effluents could improve the correlation between patient descriptions of rectal effluents and bowel preparation quality.

Methods

Before colonoscopy, patients were asked to describe the nature of their last three rectal effluents. Photographic examples of rectal effluents were provided as a reference for scoring. Bowel preparation was subsequently assessed by a single endoscopist using a global preparation assessment scale. Preparation outcomes were grouped into two levels (excellent to good vs. fair to inadequate). Both univariate and multivariate logistic regression models were used to find any association between bowel preparation quality and patient characteristics.

Results

A total of 138 patients completed the questionnaires. The mean age was 56.5±10.4 years. The mean sum of the last three rectal effluent scores was 5.9±2.0. Higher rectal effluent scores (odds ratio [OR], 0.82; P=0.043) and the presence of diverticula (OR, 0.16; P<0.001) were risk factors for suboptimal preparation.

Conclusions

Photographic example-guided patient descriptions of rectal effluents showed a statistically significant association with bowel preparation quality. However, clinical significance seemed to be low. The presence of diverticula was an independent predictive factor for suboptimal bowel preparation quality.

Citations

Citations to this article as recorded by  
  • Individualized intervention based on a preparation-related prediction model improves adequacy of bowel preparation: A prospective, multi-center, randomized, controlled study
    Long Chen, Xiaoyu Kang, Gui Ren, Hui Luo, Linhui Zhang, Limei Wang, Jianghai Zhao, Rongchun Zhang, Xiaoying Zhang, Lina Zhao, Yanglin Pan
    Digestive and Liver Disease.2024; 56(3): 436.     CrossRef
  • Comparison of Objectively Assessed Versus Patient-Reported Clarity of Last Rectal Effluent for the Prediction of Quality of Bowel Preparation for Colonoscopy: A Prospective, Case-Control Study
    Ajay Patwa, Satish Kumar, Deepak Bhagchandani, Amit Kumar, Virendra Atam, Navneet Anil, Priya Mishra, Abhishek Singh, Archana Devi, Ajay K Pal
    Cureus.2024;[Epub]     CrossRef
  • Development and validation of a novel scoring system based on a nomogram for predicting inadequate bowel preparation
    Xiaxia Zhao, Yanglin Pan, Jinyong Hao, Jie Feng, Zhongyuan Cui, Huimin Ma, Xiaojun Huang
    Clinical and Translational Oncology.2024; 26(9): 2262.     CrossRef
  • Patients' Description of Rectal Effluents Help Predict the Quality of Colonoscopy Preparation
    Manuel Antonio Lescano Lescano, Rodrigo Strehl Machado, Maria Rachel Rohr, Sender Jankiel Miszputen
    Journal of Coloproctology.2024; 44(02): e106.     CrossRef
  • Superiority of a preparation‐related model for predicting inadequate bowel preparation in patients undergoing colonoscopy: A multicenter prospective study
    Long Chen, Gui Ren, Hui Luo, Linhui Zhang, Limei Wang, Jianghai Zhao, Rongchun Zhang, Xiaoying Zhang, Xiaoyu Kang, Yanglin Pan
    Journal of Gastroenterology and Hepatology.2022; 37(12): 2297.     CrossRef
  • Comparison of bowel-cleansing efficacy of split-dose and same-day dose bowel preparation for afternoon colonoscopy in patients with gastrectomy: a prospective randomized study
    Tae-Geun Gweon, Cheal Wung Huh, Jeong Seon Ji, Chang Hyun Kim, Jin-Jo Kim, Seung-Man Park
    Surgical Endoscopy.2020; 34(10): 4413.     CrossRef
  • Evaluating the practice of canceling colonoscopies for presumed inadequate bowel preparation
    Reid L. Hopkins, David Parsons, Leonie Hoyo, Brian C. Jacobson
    Gastrointestinal Endoscopy.2020; 92(2): 382.     CrossRef
  • A Randomized Controlled Trial Comparing Colonoscopic Enema With Additional Oral Preparation as a Salvage for Inadequate Bowel Cleansing Before Colonoscopy
    Hyo-Joon Yang, Dong Il Park, Soo-Kyung Park, Sunyong Kim, Taeheon Lee, Yunho Jung, Chang Soo Eun, Dong Soo Han
    Journal of Clinical Gastroenterology.2019; 53(8): e308.     CrossRef
  • Comparison of Bowel Cleansing Efficacy, Safety, Bowel Movement Kinetics, and Patient Tolerability of Same-Day and Split-Dose Bowel Preparation Using 4 L of Polyethylene Glycol: A Prospective Randomized Study
    Myeongsook Seo, Tae-Geun Gweon, Cheal Wung Huh, Jeong Seon Ji, Hwang Choi
    Diseases of the Colon & Rectum.2019; 62(12): 1518.     CrossRef
  • Randomized trial comparing oral sulfate solution with 4‐L polyethylene glycol administered in a split dose as preparation for colonoscopy
    Hyo‐Joon Yang, Soo‐Kyung Park, Jee Hyun Kim, Jong Pil Im, Dong Han Yeom, Geom Seog Seo, Dong Il Park
    Journal of Gastroenterology and Hepatology.2017; 32(1): 12.     CrossRef
  • Patient Description of Rectal Effluents With Photographic Examples as a Predictive Indicator for the Quality of Bowel Preparation
    Hyoun Woo Kang
    Intestinal Research.2015; 13(4): 362.     CrossRef
  • Author's Reply
    Hoonsub So, Seungbong Han, Dong-Hoon Yang
    Intestinal Research.2015; 13(4): 364.     CrossRef
  • 25,699 View
  • 80 Download
  • 12 Web of Science
  • 12 Crossref
Close layer
Risk Factors for Delayed Post-Polypectomy Bleeding
Min Jung Kwon, You Sun Kim, Song I Bae, Young Il Park, Kyung Jin Lee, Jung Hwa Min, Soo Yeon Jo, Mi Young Kim, Hye Jin Jung, Seong Yeon Jeong, Won Jae Yoon, Jin Nam Kim, Jeong Seop Moon
Intest Res 2015;13(2):160-165.   Published online April 27, 2015
DOI: https://doi.org/10.5217/ir.2015.13.2.160
AbstractAbstract PDFPubReader
<b>Background/Aims</b><br/>

Among the many complications that can occur following therapeutic endoscopy, bleeding is the most serious, which occurs in 1.0-6.1% of all colonoscopic polypectomies. The aim of this study was to identify risk factors of delayed post-polypectomy bleeding (PPB).

Methods

We retrospectively reviewed the data of patients who underwent colonoscopic polypectomy between January 2003 and December 2012. We compared patients who experienced delayed PPB with those who did not. The control-to-patient ratio was 3:1. The clinical data analyzed included polyp size, number, location, and shape, patient' body mass index (BMI), preventive hemostasis, and endoscopist experience.

Results

Of 1,745 patients undergoing colonoscopic polypectomy, 21 (1.2%) experienced significant delayed PPB. We selected 63 age- and sex-matched controls. Multivariate logistic regression analysis showed that polyps >10 mm (odds ratio [OR], 2.605; 95% confidence interval [CI], 1.035-4.528; P=0.049), a pedunculated polyp (OR, 3.517; 95% CI, 1.428-7.176; P=0.045), a polyp located in the right hemicolon (OR, 3.10; 95% CI, 1.291-5.761; P=0.013), and a high BMI (OR, 3.681; 95% CI, 1.876-8.613; P=0.013) were significantly associated with delayed PPB.

Conclusions

Although delayed PPB is a rare event, more caution is needed during colonoscopic polypectomies performed in patients with high BMI or large polyps, pedunculated polyps, or polyps located in the right hemicolon.

Citations

Citations to this article as recorded by  
  • The Use of Clips to Prevent Post-Polypectomy Bleeding: A Clinical Review
    Matthew A. O’Mara, Peter G. Emanuel, Aaron Tabibzadeh, Robert J. Duve, Jonathan S. Galati, Gregory Laynor, Samantha Gross, Seth A. Gross
    Journal of Clinical Gastroenterology.2024; 58(8): 739.     CrossRef
  • Is endoscopic hemostasis safe and effective for delayed post-polypectomy bleeding?
    Jae-Yong Cho, Yunho Jung, Han Hee Lee, Jung-Wook Kim, Kee Myung Lee, Hyun Lim, Geun-Hyuk Choi, Seong Woo Choi, Bo-In Lee
    International Journal of Gastrointestinal Intervention.2024; 13(4): 122.     CrossRef
  • Colonic polypectomy in 2024: hot or cold?
    K Ferdinande, L Desomer, D De Looze, D.J. Tate
    Acta Gastro Enterologica Belgica.2024; 87(4): 505.     CrossRef
  • Cost-Effectiveness of Earlier or More Intensive Colorectal Cancer Screening in Overweight and Obese Patients
    Aaron Yeoh, Ajitha Mannalithara, Uri Ladabaum
    Clinical Gastroenterology and Hepatology.2023; 21(2): 507.     CrossRef
  • Prophylactic clipping to prevent delayed colonic post-polypectomy bleeding: meta-analysis of randomized and observational studies
    Kirles Bishay, Zhao Wu Meng, Levi Frehlich, Matthew T. James, Gilaad G. Kaplan, Michael J. Bourke, Robert J. Hilsden, Steven J. Heitman, Nauzer Forbes
    Surgical Endoscopy.2022; 36(2): 1251.     CrossRef
  • Establishment of a model for predicting delayed post-polypectomy bleeding: A real-world retrospective study
    Yu Lu, Xiaoying Zhou, Han Chen, Chao Ding, Xinmin Si
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • Blood group O is a risk factor for delayed post-polypectomy bleeding
    Hiroto Furuhashi, Akira Dobashi, Naoto Tamai, Nana Shimamoto, Masakuni Kobayashi, Shingo Ono, Yuko Hara, Hiroaki Matsui, Shunsuke Kamba, Hideka Horiuchi, Akio Koizumi, Tomohiko R. Ohya, Masayuki Kato, Keiichi Ikeda, Hiroshi Arakawa, Kazuki Sumiyama
    Surgical Endoscopy.2021; 35(12): 6882.     CrossRef
  • Effect of Instruction on Preventing Delayed Bleeding after Colorectal Polypectomy and Endoscopic Mucosal Resection
    Takuya Okugawa, Tadayuki Oshima, Keisuke Nakai, Hirotsugu Eda, Akio Tamura, Ken Hara, Tomohiro Ogawa, Tomoaki Kono, Takashi Kondo, Katsuyuki Tozawa, Masashi Fukushima, Toshihiko Tomita, Hirokazu Fukui, Jiro Watari, Hiroto Miwa
    Journal of Clinical Medicine.2021; 10(5): 928.     CrossRef
  • Endoscopic characteristics influencing postpolypectomy bleeding in 1147 consecutive pedunculated colonic polyps: a multicenter retrospective study
    Teppei Tagawa, Masayoshi Yamada, Takeyoshi Minagawa, Masanori Sekiguchi, Kenichi Konda, Hirohito Tanaka, Hiroyuki Takamaru, Masau Sekiguchi, Taku Sakamoto, Takahisa Matsuda, Aya Kuchiba, Hitoshi Yoshida, Yutaka Saito
    Gastrointestinal Endoscopy.2021; 94(4): 803.     CrossRef
  • Delayed Bleeding After Endoscopic Resection of Colorectal Polyps: Identifying High-Risk Patients
    Oliver Bendall, Joel James, Katarzyna M Pawlak, Sauid Ishaq, J Andy Tau, Noriko Suzuki, Steven Bollipo, Keith Siau
    Clinical and Experimental Gastroenterology.2021; Volume 14: 477.     CrossRef
  • Prevention of delayed post-polypectomy bleeding: Should we amend the 2017 ESGE Guideline?
    Alexandra Mack, Dileep Mangira, Alan Moss
    Endoscopy International Open.2020; 08(09): E1111.     CrossRef
  • Prophylactic hemoclips in prevention of delayed post-polypectomy bleeding for ≥ 1 cm colorectal polyps: meta-analysis of randomized controlled trials
    Faisal Kamal, Muhammad A. Khan, Salman Khan, Hemnishil K. Marella, Tamara Nelson, Zubair Khan, Dina Ahmad, Claudio Tombazzi, Mohammad K. Ismail, Colin W. Howden
    Endoscopy International Open.2020; 08(09): E1102.     CrossRef
  • Child-Pugh B or C Cirrhosis Increases the Risk for Bleeding Following Colonoscopic Polypectomy
    Hosim Soh, Jaeyoung Chun, Seung Wook Hong, Seona Park, Yun Bin Lee, Hyun Jung Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jong Pil Im, Yoon Jun Kim, Joo Sung Kim, Jung-Hwan Yoon
    Gut and Liver.2020; 14(6): 755.     CrossRef
  • Risk factors for delayed hemorrhage after colonoscopic postpolypectomy: Polyp size and operative modality
    Changqin Liu, Ruijin Wu, Xiaomin Sun, Chunhua Tao, Zhanju Liu
    JGH Open.2019; 3(1): 61.     CrossRef
  • Risk factors for severe complications of colonoscopy in screening programs
    Mercedes Vanaclocha-Espi, Josefa Ibáñez, Ana Molina-Barceló, María José Valverde-Roig, Elena Pérez, Andreu Nolasco, Mariola de la Vega, Isabel Diez de la Lastra-Bosch, María Elena Oceja, Josep Alfons Espinàs, Rebeca Font, Francisco Pérez-Riquelme, Eunate
    Preventive Medicine.2019; 118: 304.     CrossRef
  • Adverse events related to colonoscopy: Global trends and future challenges
    Su Young Kim, Hyun-Soo Kim, Hong Jun Park
    World Journal of Gastroenterology.2019; 25(2): 190.     CrossRef
  • Clips for managing perforation and bleeding after colorectal endoscopic mucosal resection
    A. S. Turan, G. Ultee, E. J. M. Van Geenen, P. D. Siersema
    Expert Review of Medical Devices.2019; 16(6): 493.     CrossRef
  • Prospective analysis of delayed colorectal post-polypectomy bleeding
    Soo-Kyung Park, Jeong Yeon Seo, Min-Gu Lee, Hyo-Joon Yang, Yoon Suk Jung, Kyu Yong Choi, Hungdai Kim, Hyung Ook Kim, Kyung Uk Jung, Ho-Kyung Chun, Dong Il Park
    Surgical Endoscopy.2018; 32(7): 3282.     CrossRef
  • Histologic discrepancy between endoscopic forceps biopsy and endoscopic mucosal resection specimens of colorectal polyp in actual clinical practice
    Moon Joo Hwang, Kyeong Ok Kim, A Lim Kim, Si Hyung Lee, Byung Ik Jang, Tae Nyeun Kim
    Intestinal Research.2018; 16(3): 475.     CrossRef
  • Screening colonoscopy and risk of adverse events among individuals undergoing fecal immunochemical testing in a population‐based program: A nested case‐control study
    Eunate Arana-Arri, Natale Imaz-Ayo, Mari Jose Fernández, Isabel Idigoras, Isabel Bilbao, Luis Bujanda, Fidencio Bao, Enrique Ojembarrena, Ines Gil, Iñaki Gutiérrez-Ibarluzea, Isabel Portillo
    United European Gastroenterology Journal.2018; 6(5): 755.     CrossRef
  • Evaluation and management of lower gastrointestinal bleeding
    Aun Raza Shah, Vikram Jala, Hammad Arshad, Mohammad Bilal
    Disease-a-Month.2018; 64(7): 321.     CrossRef
  • Endoscopic treatment of surgery or procedure-related gastrointestinal bleeding
    Ki Bae Bang, Hyun Deok Shin
    International Journal of Gastrointestinal Intervention.2018; 7(3): 112.     CrossRef
  • Risk factors for delayed colonic post-polypectomy bleeding: a systematic review and meta-analysis
    Veeravich Jaruvongvanich, Narut Prasitlumkum, Buravej Assavapongpaiboon, Sakolwan Suchartlikitwong, Anawin Sanguankeo, Sikarin Upala
    International Journal of Colorectal Disease.2017; 32(10): 1399.     CrossRef
  • Association between the ulcer status and the risk of delayed bleeding after the endoscopic mucosal resection of colon
    Gwang‐Un Kim, Myeongsook Seo, Eun Mi Song, Sung Wook Hwang, Sang Hyoung Park, Dong‐Hoon Yang, Jeong‐Sik Byeon
    Journal of Gastroenterology and Hepatology.2017; 32(11): 1846.     CrossRef
  • Clinical outcome of endoscopic management in delayed postpolypectomy bleeding
    Jeong-Mi Lee, Wan Soo Kim, Min Seob Kwak, Sung-Wook Hwang, Dong-Hoon Yang, Seung-Jae Myung, Suk-Kyun Yang, Jeong-Sik Byeon
    Intestinal Research.2017; 15(2): 221.     CrossRef
  • Are Hemorrhoids Associated with False-Positive Fecal Immunochemical Test Results?
    Nam Hee Kim, Jung Ho Park, Dong Il Park, Chong Il Sohn, Kyuyong Choi, Yoon Suk Jung
    Yonsei Medical Journal.2017; 58(1): 150.     CrossRef
  • Prediction and Prevention of Postpolypectomy Bleeding: Necessity of a Different Approach for Patients Using Antithrombotic Agents
    Duk Hwan Kim
    Clinical Endoscopy.2017; 50(3): 217.     CrossRef
  • Serum CEA and CA 19-9 Levels are Associated with the Presence and Severity of Colorectal Neoplasia
    Nam Hee Kim, Mi Yeon Lee, Jung Ho Park, Dong Il Park, Chong Il Sohn, Kyuyong Choi, Yoon Suk Jung
    Yonsei Medical Journal.2017; 58(5): 918.     CrossRef
  • A Quality Improvement Educational Intervention to Increase Knowledge of Cardiogastroenterology Amongst Medical Trainees and Nursing Staff
    Elena Fradkov, Alexander Goldowsky, Kirsten Quiles, Renee Williams
    MedEdPORTAL.2017;[Epub]     CrossRef
  • New Quality Measure Will Disincentivize Endoscopic Resection of Most Important Colorectal Lesions
    Douglas K. Rex, Thomas F. Imperiale
    Gastroenterology.2016; 150(5): 1249.     CrossRef
  • A new quality indicator of colonoscopy: caveat emptor
    Thomas F. Imperiale, Douglas K. Rex
    Gastrointestinal Endoscopy.2016; 84(3): 507.     CrossRef
  • Anesthetist-Directed Sedation for Colonoscopy: A Safe Haven or Siren’s Song?
    Douglas K. Rex, John J. Vargo
    Gastroenterology.2016; 150(4): 801.     CrossRef
  • Complication de la coloscopie
    D. Heresbach
    EMC - Gastro-entérologie.2016; 33(4): 1.     CrossRef
  • 18,364 View
  • 81 Download
  • 37 Web of Science
  • 33 Crossref
Close layer
Case Reports
Usefulness of Adalimumab for Treating a Case of Intestinal Behçet's Disease With Trisomy 8 Myelodysplastic Syndrome
Masamichi Kimura, Yoshihisa Tsuji, Masako Iwai, Masahiro Inagaki, Ali Madian, Takuya Yoshino, Minoru Matsuura, Hiroshi Nakase
Intest Res 2015;13(2):166-169.   Published online April 27, 2015
DOI: https://doi.org/10.5217/ir.2015.13.2.166
AbstractAbstract PDFPubReader

Behçet's disease (BD) is a systemic vasculitis, while myelodysplastic syndrome (MDS) is a heterogeneous group of clonal hematologic disorders characterized by ineffective hematopoiesis. Some studies suggest a relationship between MDS and BD, especially intestinal BD, and trisomy 8 seems to play an important role in both diseases. There are several reports on patients with BD comorbid with MDS involving trisomy 8 that frequently have intestinal lesions refractory to conventional medical therapies. Tumor necrosis factor (TNF)-α is strongly involved in the pathophysiology of several autoimmune diseases such as rheumatoid arthritis, inflammatory bowel disease, and BD. In addition, TNF-α plays an important role in the pathophysiology of MDS by inhibiting normal hematopoiesis and inducing the programmed cell death of normal total bone marrow cells and normal CD34+ cells. Recent clinical reports demonstrate the favorable effect of TNF-α antagonists in patients with refractory intestinal BD and in those with MDS. We present the case of a patient with intestinal BD and MDS involving trisomy 8 who was successfully treated with adalimumab.

Citations

Citations to this article as recorded by  
  • The Expanding Spectrum of Autoinflammatory Diseases
    Kiyoshi Migita, Yuya Fujita, Tomoyuki Asano, Shuzo Sato
    Internal Medicine.2023; 62(1): 43.     CrossRef
  • Refractory Intestinal Behçet-Like Disease Associated with Trisomy 8 Myelodysplastic Syndrome Resolved by Parenteral Nutrition
    Ryo Takahashi, Yasuo Matsubara, Satoshi Takahashi, Kazuaki Yokoyama, Lim Lay Ahyoung, Michiko Koga, Hiroyuki Sakamoto, Narikazu Boku, Dai Shida, Hiroshi Yotsuyanagi
    Case Reports in Gastroenterology.2023; 17(1): 287.     CrossRef
  • The Expanding Spectrum of Autoinflammatory Diseases
    Kiyoshi Migita, Yuya Fujita, Tomoyuki Asano, Shuzo Sato
    Internal Medicine.2022;[Epub]     CrossRef
  • CAISC: A software to integrate copy number variations and single nucleotide mutations for genetic heterogeneity profiling and subclone detection by single-cell RNA sequencing
    Jeerthi Kannan, Liza Mathews, Zhijie Wu, Neal S. Young, Shouguo Gao
    BMC Bioinformatics.2022;[Epub]     CrossRef
  • Autoimmune disorders associated with myelodysplastic syndromes: clinical, prognostic and therapeutic implications
    Claudio Fozza, Andrea Murtas, Giovanni Caocci, Giorgio La Nasa
    Leukemia Research.2022; 117: 106856.     CrossRef
  • Advances in Management of Intestinal Behçet’s Disease: A Perspective From Gastroenterologists
    Jae Hee Cheon
    Journal of Rheumatic Diseases.2021; 28(1): 4.     CrossRef
  • Syndrome de pseudo-Behçet et autres manifestations dysimmunitaires associées aux syndromes myélodysplasiques avec trisomie 8
    N. Wesner, P. Fenaux, V. Jachiet, L. Ades, O. Fain, A. Mekinian
    La Revue de Médecine Interne.2021; 42(3): 170.     CrossRef
  • The Clinical Features of Intestinal Disease in Myelodysplastic Syndromes with Trisomy 8
    Yusuke Honzawa
    Nippon Daicho Komonbyo Gakkai Zasshi.2021; 74(10): 594.     CrossRef
  • Update on the Treatment of Behcet’s Disease of the Small Bowel with Biologic Agents
    Yehyun Park, Jae Hee Cheon
    Current Gastroenterology Reports.2020;[Epub]     CrossRef
  • How to treat myelodysplastic syndrome with clinical features resembling Behçet syndrome: a case-based systematic review
    Umut Yilmaz, Muhlis Cem Ar, Sinem Nihal Esatoglu, Isil Bavunoglu, Yusuf Ziya Erzin, Ali Ibrahim Hatemi, Suleyman Yildirim, Gülen Hatemi, Aykut Ferhat Celik
    Annals of Hematology.2020; 99(6): 1193.     CrossRef
  • Evidence-based diagnosis and clinical practice guidelines for intestinal Behçet’s disease 2020 edited by Intractable Diseases, the Health and Labour Sciences Research Grants
    Kenji Watanabe, Satoshi Tanida, Nagamu Inoue, Reiko Kunisaki, Kiyonori Kobayashi, Masakazu Nagahori, Katsuhiro Arai, Motoi Uchino, Kazutaka Koganei, Taku Kobayashi, Mitsuhiro Takeno, Fumiaki Ueno, Takayuki Matsumoto, Nobuhisa Mizuki, Yasuo Suzuki, Tadakaz
    Journal of Gastroenterology.2020; 55(7): 679.     CrossRef
  • Sonic hedgehog signaling pathway in Myelodysplastic Syndrome: Abnormal activation and jervine intervention
    YuTing Qin, Ming Jiang, Nilupar Tuerxung, Huan Wang, Fang Zhao, Yin Zhen, Jianping Hao
    Gene.2020; 754: 144881.     CrossRef
  • Gastrointestinal Behcet’s-like disease with myelodysplastic neoplasms with trisomy 8: a French case series and literature review
    Nadege Wesner, Louis Drevon, Alexis Guedon, Jean Baptiste Fraison, Benjamin Terrier, Salim Trad, Jean Emmanuel Kahn, Achille Aouba, Jerome Gillard, Matthieu Ponsoye, Thomas Hanslik, Clement Gourguechon, Eric Liozon, Kamel Laribi, Julien Rossignol, Olivier
    Leukemia & Lymphoma.2019; 60(7): 1782.     CrossRef
  • Usefulness of Ustekinumab for Treating a Case of Myelodysplastic Syndrome-associated Inflammatory Bowel Disease
    Masashi Kono, Toshiharu Sakurai, Kazuki Okamoto, Tomoyuki Nagai, Yoriaki Komeda, Hiroshi Kashida, Kosuke Minaga, Ken Kamata, Mamoru Takenaka, Satoru Hagiwara, Tomohiro Watanabe, Naoshi Nishida, Eisuke Enoki, Hiroaki Inoue, Itaru Matsumura, Masatoshi Kudo
    Internal Medicine.2019; 58(14): 2029.     CrossRef
  • Intestinal Behçet disease associated with myelodysplastic syndrome accompanying trisomy 8 successfully treated with abdominal surgery followed by hematopoietic stem cell transplantation
    Tomoyuki Asano, Shuzo Sato, Makiko Yashiro Furuya, Hiroshi Takahashi, Akiko Shichishima-Nakamura, Hiroshi Ohkawara, Tatsuo Fujiwara, Naohiko Gunji, Choichiro Hashimoto, Tomoyuki Momma, Motonobu Saito, Hiroshi Nakano, Guy Watanabe, Jumpei Temmoku, Yuya Fuj
    Medicine.2019; 98(46): e17979.     CrossRef
  • Long-term maintenance of the mucosal healing induced by azacitidine therapy in a patient with intestinal Behçet’s-like disease accompanied with myelodysplastic syndrome involving trisomy 8
    Nahoko Tanaka, Hirotake Sakuraba, Hiroto Hiraga, Ko Mayama, Hidezumi Kikuchi, Dai Kishida, Yui Akemoto, Keisuke Hasui, Shinji Ota, Rina Watanabe, Yasuhisa Murai, Takato Maeda, Kosuke Kamata, Tetsuya Tatsuta, Manabu Sawaya, Daisuke Chinda, Tatsuya Mikami,
    Immunological Medicine.2019; 42(3): 135.     CrossRef
  • Updated treatment strategies for intestinal Behçet’s disease
    Yong Eun Park, Jae Hee Cheon
    The Korean Journal of Internal Medicine.2018; 33(1): 1.     CrossRef
  • High Incidence of Gastrointestinal Ulceration and Cytogenetic Aberration of Trisomy 8 as Typical Features of Behçet’s Disease Associated with Myelodysplastic Syndrome: A Series of 16 Consecutive Chinese Patients from the Shanghai Behçet’s Disease Database
    Yan Shen, Hai-Fen Ma, Dan Luo, Jian-Fei Cai, Jun Zou, Jian-Long Guan
    BioMed Research International.2018; 2018: 1.     CrossRef
  • Anti-Tumor Necrosis Factor Therapy in Intestinal Beh Ccedil;et rsquo;s Disease
    Jihye Park, Jae Hee Cheon
    Gut and Liver.2018; 12(6): 623.     CrossRef
  • Update on the Medical Management of Gastrointestinal Behçet’s Disease
    Giuseppe Lopalco, Donato Rigante, Vincenzo Venerito, Claudia Fabiani, Rossella Franceschini, Michele Barone, Giovanni Lapadula, Mauro Galeazzi, Bruno Frediani, Florenzo Iannone, Luca Cantarini
    Mediators of Inflammation.2017; 2017: 1.     CrossRef
  • Risk factors and outcomes of acute lower gastrointestinal bleeding in intestinal Behçet’s disease
    Jihye Park, Jae Hee Cheon, Yong Eun Park, Yoon Jee Lee, Hyun Jung Lee, Soo Jung Park, Sung Pil Hong, Tae Il Kim, Won Ho Kim
    International Journal of Colorectal Disease.2017; 32(5): 745.     CrossRef
  • 18F-FDG PET/CT Findings in Two Cases With Myelodysplastic Syndrome Accompanied by Behçet’s Disease
    Kimiteru Ito, Kazuo Kubota
    Clinical Nuclear Medicine.2016; 41(8): e392.     CrossRef
  • Multiple colonic ulcers associated with trisomy 8: serial changes in colonoscopic findings
    Shunichi Yanai, Shotaro Nakamura, Keisuke Kawasaki, Shigeki Ito, Tamotsu Sugai, Takayuki Matsumoto
    Clinical Journal of Gastroenterology.2016; 9(5): 298.     CrossRef
  • Acute Monocytic Leukemia Masquerading Behçet’s Disease-Like Illness at Onset in an Elderly Female
    Shigeru Koba, Toshio Sekioka, Sorou Takeda, Aya Miyagawa-Hayashino, Keisuke Nishimura, Shinsaku Imashuku
    Case Reports in Hematology.2016; 2016: 1.     CrossRef
  • 9,917 View
  • 86 Download
  • 23 Web of Science
  • 24 Crossref
Close layer
Primary Anorectal Malignant Melanoma Treated With Endoscopic Mucosal Resection
Jong Hoon Park, Jeong Rok Lee, Hyung Seok Yoon, Tae Young Jung, Eun Joo Lee, Jong Gu Lim, Soon Young Ko, Joon Ho Wang, Jae Dong Lee, Hye Young Kim
Intest Res 2015;13(2):170-174.   Published online April 27, 2015
DOI: https://doi.org/10.5217/ir.2015.13.2.170
AbstractAbstract PDFPubReader

Anorectal melanoma is a rare neoplasm that accounts for less than 1-4% of anorectal malignant tumors. The main therapeutic modality for anorectal melanoma is surgical treatment, with abdominoperineal resection or wide local excision being the most common approaches. A 77-year-old male with a history of cerebral infarction and hypertension presented with anal bleeding. Here, we report a case of anorectal melanoma treated by endoscopic mucosal resection with adjuvant interferon therapy rather than surgical resection. The patient has been disease-free for 5 years after endoscopic treatment.

Citations

Citations to this article as recorded by  
  • Anorectal melanoma: Report of two cases
    Anass El Achchi, Amine Majdoubi, Mohamed El Hammouti, Tarek Bouhout, Badr Serji
    International Journal of Surgery Case Reports.2025; 126: 110621.     CrossRef
  • A nuanced exploration delving into malignant melanomas occurring in unexpected and less common anatomical locations
    Reena Sinha, Md Ali Osama, Shadan Rabab, CP Jaiswal
    Journal of Family Medicine and Primary Care.2024; 13(2): 800.     CrossRef
  • Anorectal melanoma: systematic review of the current literature of an aggressive type of melanoma
    Giovanni Paolino, Antonio Podo Brunetti, Carolina De Rosa, Carmen Cantisani, Franco Rongioletti, Andrea Carugno, Nicola Zerbinati, Mario Valenti, Domenico Mascagni, Giulio Tosti, Santo Raffaele Mercuri, Riccardo Pampena
    Melanoma Research.2024; 34(6): 487.     CrossRef
  • Primary malignant melanoma of rectum: A rare case report
    Ramin Saadaat, Saifullah, Mohammad Asef Adelyar, Esmatullah Esmat Rasool, Jamshid Abdul-Ghafar, Ahmed Maseh Haidary
    International Journal of Surgery Case Reports.2023; 104: 107942.     CrossRef
  • Primary anorectal amelanotic melanoma with liver, lungs and lymph nodal metastases
    James R Marak, Gaurav Raj, Shivam Dwivedi, Ariba Zaidi
    BMJ Case Reports.2023; 16(11): e257510.     CrossRef
  • Difficulties in diagnosing anorectal melanoma: A case report and review of the literature
    Raluca Cristina Apostu, Elena Stefanescu, Radu Razvan Scurtu, Gabriel Kacso, Radu Drasovean
    World Journal of Clinical Cases.2021; 9(36): 11369.     CrossRef
  • Early primary anorectal malignant melanoma treated with endoscopic submucosal dissection: a case report
    Jingjing Lian, Aiping Xu, Yuan Chu, Tao Chen, Meidong Xu
    International Journal of Colorectal Disease.2020; 35(5): 959.     CrossRef
  • A case report of anorectal malignant melanoma in the transitional zone
    Minh Thao Nguyen, Van Mao Nguyen, Van Huy Tran, Anh Vu Pham
    International Journal of Surgery Case Reports.2020; 75: 264.     CrossRef
  • Endoscopic submucosal dissection as excisional biopsy for anorectal malignant melanoma: A case report
    Shigeo Manabe, Yoshio Boku, Michiyo Takeda, Fumitaka Usui, Ikuhiro Hirata, Shuji Takahashi
    World Journal of Clinical Cases.2019; 7(13): 1652.     CrossRef
  • Primary malignant melanoma without melanosis of the colon
    Nam Hee Yi, Sang Heon Lee, Sang Heon Lee, Ji Hyun Kim, Sam Ryong Jee, Sang Yong Seol
    Intestinal Research.2019; 17(4): 561.     CrossRef
  • Rectal melanoma: epidemiology, prognosis, and role of adjuvant radiation therapy
    Leila Tchelebi, Adel Guirguis, Hani Ashamalla
    Journal of Cancer Research and Clinical Oncology.2016; 142(12): 2569.     CrossRef
  • 5,896 View
  • 45 Download
  • 12 Web of Science
  • 11 Crossref
Close layer
Natural Course of an Untreated Metastatic Perirectal Lymph Node After the Endoscopic Resection of a Rectal Neuroendocrine Tumor
Sang Hyung Kim, Dong-Hoon Yang, Jung Su Lee, Soyoung Park, Ho-Su Lee, Hyojeong Lee, Sang Hyoung Park, Kyung-Jo Kim, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Jin-Ho Kim, Chan Wook Kim, Jihun Kim
Intest Res 2015;13(2):175-179.   Published online April 27, 2015
DOI: https://doi.org/10.5217/ir.2015.13.2.175
AbstractAbstract PDFPubReader

Lymph node metastasis is rare in small (i.e., <10 mm) rectal neuroendocrine tumors (NETs). In addition to tumor size, pathological features such as the mitotic or Ki-67 proliferation index are associated with lymph node metastasis in rectal NETs. We recently treated a patient who underwent endoscopic treatment of a small, grade 1 rectal NET that recurred in the form of perirectal lymph node metastasis 7 years later. A 7-mm-sized perirectal lymph node was noted at the time of the initial endoscopic treatment. The same lymph node was found to be slightly enlarged on follow-up and finally confirmed as a metastatic NET. Therefore, the perirectal lymph node metastasis might have been present at the time of the initial diagnosis. However, the growth rate of the lymph node was extremely low, and it took 7 years to increase in size from 7 to 10 mm. NETs with low Ki-67 proliferation index and without mitotic activity may grow extremely slowly even if they are metastatic.

Citations

Citations to this article as recorded by  
  • Clinical application of endoscopic ultrasonography in the management of rectal neuroendocrine tumors
    Soo-Young Na, Seong Jung Kim, Hyoun Woo Kang
    International Journal of Gastrointestinal Intervention.2023; 12(3): 105.     CrossRef
  • Tumor grade 2 as the independent predictor for lymph node metastasis in 10–20 mm sized rectal neuroendocrine tumor
    Byung-Soo Park, Sung Hwan Cho, Gyung Mo Son, Hyun Sung Kim, Su Jin Kim, Su Bum Park, Cheol Woong Choi, Hyung Wook Kim, Dong Hoon Shin
    Korean Journal of Clinical Oncology.2021; 17(1): 37.     CrossRef
  • Lymphovascular invasion as a prognostic value in small rectal neuroendocrine tumor treated by local excision: A systematic review and meta-analysis
    Ho Suk Kang, Mi Jung Kwon, Tae-Hwan Kim, Junhee Han, Young-Su Ju
    Pathology - Research and Practice.2019; 215(11): 152642.     CrossRef
  • Trans‐anal full‐thickness endoscopic resection of a rectal neuroendocrine neoplasm performed with a TEO® (Karl Storz microsurgery device) and laparoscopic indocyanine‐green‐guided lymphatic sampling – a video vignette
    P. Leon, A. Balduzzi, M. Troian, N. de Manzini
    Colorectal Disease.2017; 19(4): 399.     CrossRef
  • Usefulness of endoscopic resection using the band ligation method for rectal neuroendocrine tumors
    Ju Seung Kim, Yoon Jae Kim, Jun-Won Chung, Jung Ho Kim, Kyoung Oh Kim, Kwang An Kwon, Dong Kyun Park, Jung Suk An
    Intestinal Research.2016; 14(2): 164.     CrossRef
  • Lymphovascular invasion in more than one-quarter of small rectal neuroendocrine tumors
    Mi Jung Kwon, Ho Suk Kang, Jae Seung Soh, Hyun Lim, Jong Hyeok Kim, Choong Kee Park, Hye-Rim Park, Eun Sook Nam
    World Journal of Gastroenterology.2016; 22(42): 9400.     CrossRef
  • Cap-assisted EMR for rectal neuroendocrine tumors: comparisons with conventional EMR and endoscopic submucosal dissection (with videos)
    Dong-Hoon Yang, Yangsoon Park, Sang Hyoung Park, Kyung-Jo Kim, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang
    Gastrointestinal Endoscopy.2016; 83(5): 1015.     CrossRef
  • Are Small Rectal Neuroendocrine Tumors Safe?
    Jae Ho Choi, Jae Myung Cha
    Intestinal Research.2015; 13(2): 103.     CrossRef
  • 7,451 View
  • 52 Download
  • 9 Web of Science
  • 8 Crossref
Close layer
Images of the Issue
A Patient Experiencing Bloody Diarrhea and Tenesmus for Three Weeks
Eun Sun Kim, Yoon Tae Jeen, Joo Young Kim
Intest Res 2015;13(2):180-181.   Published online April 27, 2015
DOI: https://doi.org/10.5217/ir.2015.13.2.180
PDFPubReader
  • 6,174 View
  • 48 Download
Close layer
Letterses to the Editor
When is an Assay of Cytomegalovirus Antigenemia Useful in Detecting Cytomegalovirus Colitis?
Kyeong Ok Kim
Intest Res 2015;13(2):182-183.   Published online April 27, 2015
DOI: https://doi.org/10.5217/ir.2015.13.2.182
PDFPubReader

Citations

Citations to this article as recorded by  
  • Author's Reply
    Jaeyoung Chun, Jong Pil Im
    Intestinal Research.2015; 13(2): 184.     CrossRef
  • 4,728 View
  • 48 Download
  • 1 Web of Science
  • 1 Crossref
Close layer
Author's Reply
Jaeyoung Chun, Jong Pil Im
Intest Res 2015;13(2):184-185.   Published online April 27, 2015
DOI: https://doi.org/10.5217/ir.2015.13.2.184
PDFPubReader
  • 8,003 View
  • 25 Download
Close layer

Intest Res : Intestinal Research
Close layer
TOP